全文获取类型
收费全文 | 13993篇 |
免费 | 1000篇 |
国内免费 | 757篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 57篇 |
妇产科学 | 58篇 |
基础医学 | 411篇 |
口腔科学 | 94篇 |
临床医学 | 419篇 |
内科学 | 484篇 |
皮肤病学 | 17篇 |
神经病学 | 145篇 |
特种医学 | 453篇 |
外科学 | 251篇 |
综合类 | 1843篇 |
一般理论 | 1篇 |
预防医学 | 819篇 |
眼科学 | 35篇 |
药学 | 7515篇 |
中国医学 | 2433篇 |
肿瘤学 | 698篇 |
出版年
2024年 | 36篇 |
2023年 | 122篇 |
2022年 | 201篇 |
2021年 | 260篇 |
2020年 | 283篇 |
2019年 | 218篇 |
2018年 | 267篇 |
2017年 | 346篇 |
2016年 | 360篇 |
2015年 | 405篇 |
2014年 | 982篇 |
2013年 | 959篇 |
2012年 | 1137篇 |
2011年 | 1290篇 |
2010年 | 1015篇 |
2009年 | 856篇 |
2008年 | 957篇 |
2007年 | 959篇 |
2006年 | 798篇 |
2005年 | 688篇 |
2004年 | 522篇 |
2003年 | 447篇 |
2002年 | 353篇 |
2001年 | 269篇 |
2000年 | 231篇 |
1999年 | 207篇 |
1998年 | 150篇 |
1997年 | 154篇 |
1996年 | 165篇 |
1995年 | 137篇 |
1994年 | 99篇 |
1993年 | 97篇 |
1992年 | 99篇 |
1991年 | 64篇 |
1990年 | 67篇 |
1989年 | 104篇 |
1988年 | 69篇 |
1987年 | 41篇 |
1986年 | 40篇 |
1985年 | 42篇 |
1984年 | 41篇 |
1983年 | 23篇 |
1982年 | 26篇 |
1981年 | 27篇 |
1980年 | 19篇 |
1979年 | 19篇 |
1978年 | 22篇 |
1977年 | 13篇 |
1976年 | 11篇 |
1975年 | 10篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
Purpose
Chest wall pain is an uncommon but bothersome late complication following lung stereotactic body radiation therapy. Despite numerous studies investigating predictors of chest wall pain, no clear consensus has been established for a chest wall constraint. The aim of our study was to investigate factors related to chest wall pain in a homogeneous group of patients treated at our institution.Patients and methods
All 122 patients were treated with the same stereotactic body radiation therapy regimen of 48 Gy in three fractions, seen for at least 6 months of follow-up, and planned with heterogeneity correction. Chest wall pain was scored according to the Common Terminology Criteria for Adverse Events classification v3.0. Patient (age, sex, diabetes, osteoporosis), tumour (planning target volume, volume of the overlapping region between planning target volume and chest wall) and chest wall dosimetric parameters (volumes receiving at least 30, 40, and 50 Gy, the minimal doses received by the highest irradiated 1, 2, and 5 cm3, and maximum dose) were collected. The correlation between chest wall pain (grade 2 or higher) and the different parameters was evaluated using univariate and multivariate logistic regression.Results
Median follow-up was 18 months (range: 6–56 months). Twelve patients out of 122 developed chest wall pain of any grade (seven with grade 1, three with grade 2 and two with grade 3 pain). In univariate analysis, only the volume receiving 30 Gy or more (P = 0.034) and the volume of the overlapping region between the planning target volume and chest wall (P = 0.038) significantly predicted chest wall pain, but these variables were later proved non-significant in multivariate regression.Conclusion
Our analysis could not find any correlation between the studied parameters and chest wall pain. Considering our present study and the wide range of differing results from the literature, a reasonable conclusion is that a constraint for chest wall pain is yet to be defined. 相似文献3.
In vitro to in vivo extrapolation (IVIVE) for next-generation risk assessment (NGRA) of chemicals requires computational modeling and faces unique challenges. Using mitochondria-related toxicity data of troglitazone (TGZ), a prototype drug known for liver toxicity, from HepaRG, HepG2, HC-04, and primary human hepatocytes, we explored inherent uncertainties in IVIVE, including cell models, cellular response endpoints, and dose metrics. A human population physiologically-based pharmacokinetic (PBPK) model for TGZ was developed to predict in vivo doses from in vitro point-of-departure (POD) concentrations. Compared to the 200–800 mg/d dose range of TGZ where liver injury was observed clinically, the predicted POD doses for the mean and top one percentile of the PBPK population were 28–372 and 15–178 mg/d respectively based on Cmax dosimetry, and 185–2552 and 83–1010 mg/d respectively based on AUC. In conclusion, although with many uncertainties, integrating in vitro assays and PBPK modeling is promising in informing liver toxicity-inducing TGZ doses. 相似文献
4.
Keyang Qian Hanqing Qian Juan Cai Wuheng Yue Xiaoxiao Yu Baorui Liu 《Pathology, research and practice》2019,215(4):755-760
Gastric cancer, one of the most common disease, has become a major public health problem worldwide. Cisplatin (DDP) has been a widely used drug for the treatment of cancer, also usually applied in gastric cancer in clinic. However, the side effects including toxicity and drug-resistance restricted the usage of DDP in clinic, so we prepared a DDP-complexed hydrogel (DDP-Gel) and investigated its efficacy in gastric cancer. For in vivo studies, MKN45-Luc cells were injected into BLAB/C node mice subcutaneously to establish gastric cancer with orthotopically grown tumors. Mice bearing tumors were treated with normal saline, DDP and DDP-Gel. Body weight and survival condition were observed and recorded. The treatment efficacy in vivo was detected by luciferase imaging and histological evaluation was performed by H&E staining of different organs. Additionally, normal ICR mice were treated with different doses of DDP/DDP-Gel to calculate their LD50 in vivo. The results showed that DDP-Gel prolonged survival time and ameliorated body weight changes of mice bearing tumors. DDP-Gel exhibited higher efficacy to inhibit tumor growth and metastasis, compared to DDP. Besides, LD50 of DDP-Gel was 166.0?mg/kg, 13.2 folds higher than DDP. As a conclusion, DDP-Gel showed a more effective and safer function than DDP in gastric cancer, which indicating that DDP-Gel might be a novel strategy for gastric cancer therapy. 相似文献
5.
慢性肾脏病是一种以肾脏功能的损伤为主要表现,并可累及全身多脏器的慢性进展性疾病。中医辨证治疗本病在延缓病情、改善预后等方面具有显著的优势。通过中医理论研究及临床经验总结,笔者提出从“肾毒”论治慢性肾脏病,认为其不仅是本病的致病因素,更是重要的病理产物,是本病发生发展、迁延难愈的关键。在治疗上提出以“益肾元、解肾毒”为大法,并根据不同兼夹辨证施治,采用药对,长治缓图。以“肾毒”立论拟定的经验方苏茵解毒方,在临床治疗和实验研究上均显示出明显的效果,并已制备成院内制剂临床使用,在疗效及经济效益方面均具有显著的优势。 相似文献
6.
7.
抗生素的定义,首先来自于20世纪40年代链霉素的发现。在随后的几十年中,其他氨基糖苷类抗生素家族被大量发现并广泛应用,一度成为抗革兰阴性菌感染的首选抗生素。但由于其毒副作用较大,并且细菌对其不断产生耐药性,加上其他结构类别的新型抗生素的不断发现,使其一度几乎退出历史舞台。然而随着多重耐药细菌引起的感染率急剧上升,人们开始关注氨基糖苷类抗生素作为几种重要的治疗革兰阴性病原体的方案之一,并且发掘了其在治疗感染性疾病、艾滋病和遗传性疾病的潜力,使这个“老牌”抗生素重焕生机。 相似文献
8.
建立了顶空毛细管GC法测定吉非罗齐中甲酸乙酯、THF和甲基环己烷3种有机溶剂的残留量。采用HP-1毛细管柱,溶剂DMA,内标乙酸乙酯。平均同收率分别为99.8%、100.3%、100.0%,RSD分别为0.71%、1.51%和1.76%。 相似文献
9.
分别用水和乙醇作为溶剂加热提取枳椇子中的总黄酮,用比色法测定黄酮的含量,分别以提取时间、加热温度、料液比、提取次数等因素进行正交试验.对两种提取方法进行比较,确定各因素对提取效果的影响并对其解酒作用进行研究.水提取法的最优条件是:100 ℃,料液比1 g:8 mL,加热0.5 h,回流提取3次;醇提取法的最佳条件:80 ℃,料液比1 g:6 mL,加热1.5 h,以体积分数50%的乙醇回流提取3次.实验结果显示,醇提取法比水提取法效果更好,枳椇子提取液具有一定的解酒作用. 相似文献
10.
GC法测定金银三七胶囊中的冰片的含量 总被引:1,自引:0,他引:1
目的:建立金银三七胶囊中冰片的含量测定方法。方法:采用GC法,色谱柱为10%PEG-20M;FID氢火焰检测器:柱温为115℃。结果:冰片在0.02559-0.5118μg范围内线性良好。加样回收率为99.9%,RSD%为1.94%(n=9)。结论:方法简便,可行,重现性良好,结果准确,可加强金银三七胶囊的质量控制。 相似文献